Trials / Not Yet Recruiting
Not Yet RecruitingNCT07193602
VR-based Dexterity Training in MS
Home-based Virtual Reality (VR) Headset-based Dexterity Training in Multiple Sclerosis: a Randomized-controlled Trial
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Christian Kamm · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to investigate if a specifically developed home-based dexterity training intervention using a Virtual Reality (VR) Headset (Meta quest 2) improves impaired manual dexterity in persons with multiple sclerosis.
Detailed description
Subjects will be recruited during regular visits at the MS centre of the Luzerner Kantonsspital, Switzerland or at the Department of Neurology of the University Hospital Basel. Ethical approval will be obtained, and the trial will be registered in the clinicaltrials.gov database. Patients must sign informed consent prior to study entry (=Screening). If patients are eligible at screening as defined in the Inclusion- and Exclusion criteria, all primary and secondary outcome measurements will be performed at Baseline. Subjects will be randomized 1:1 in Group 1 (Training intervention) or Group 2 (Sham-Intervention) and instructed into the respective training. After 4 weeks of training, all primary and secondary outcome measurements will be repeated, and the study ends.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | VR-based dexterity training in MS | Training of limited manual dexterity in people with multiple sclerosis through a specially developed home-based dexterity training programm using a virtual headset |
| OTHER | mediation program | Sham Training is the comparator. The Sham group is performing a commercially available mediation programm TRIPP: |
Timeline
- Start date
- 2026-05-01
- Primary completion
- 2028-05-01
- Completion
- 2028-05-01
- First posted
- 2025-09-26
- Last updated
- 2026-04-13
Locations
2 sites across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT07193602. Inclusion in this directory is not an endorsement.